Brief: Chinook Therapeutics Reports Q4 And FY 2022 Financial Results And Provides Corporate Updates
Feb 27 (Reuters) - Chinook Therapeutics Inc KDNY.O :
* CHINOOK THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES
* CHINOOK THERAPEUTICS - CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES TOTALED $385.3 MILLION AS OF DEC 31, 2022, VERSUS
$355.1 MILLION AS OF DEC 31, 2021
* QTRLY REVENUE WAS $0.5 MILLION
* Q4 EARNINGS PER SHARE VIEW $-0.79, REVENUE VIEW $100000.00
--
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX4qB3S1
Further company coverage: KDNY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chinook Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Chinook Therapeutics
Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Chinook Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Brief: Chinook Therapeutics Announces First Patient Enrolled In Phase 3 Of Zigakibart
Brief: Muddy Waters- Remains Short On Chinook Therapeutics Inc